Ascendis Pharma A/S Announces U.S. Food and Drug Administration (FDA) Accepts Biologics License Application (BLA) for TransCon™ hGH for Pediatric Growth Hormone Deficiency (GHD)

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition